Related Experiment Video
Updated: Dec 15, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia
Francesco Amati1,2,3, Marcos I Restrepo3,4
1Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Abstract:
In recent decades, there has been a growing interest about the role of gram negative bacteria in community-acquired pneumonia (CAP), especially Pseudomonas aeruginosa, Enterobacteriaceae, and Acinetobacter baumannii. The prevalence of these pathogens differs largely according to the local ecology and the geographical location. Identifying gram negative bacteria, and in particular resistant gram negative bacteria, is of paramount importance in patients with CAP because these pathogens are associated with higher clinical severity and unfavorable outcomes. The use of individualized risk factors to predict each pathogen is a helpful strategy that needs to be locally validated. However, it should be taken into account that most of the risk factors identified in the literature are heterogeneously defined or lack consistency. New diagnostic techniques, such as molecular testing, are promising methods for early detection of these gram negative pathogens. The increasing mechanisms of resistance to antibiotics of these pathogens have limited our therapeutic approach. This narrative review focuses on the epidemiology, risk factors, diagnosis, and therapeutic options for the most relevant gram negative bacteria that cause CAP.
Insights
Gram-negative bacteria, including Pseudomonas aeruginosa, are increasingly implicated in community-acquired pneumonia (CAP). Early identification and understanding resistance patterns are crucial for effective treatment of CAP caused by these challenging pathogens.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Gram-negative bacteria are an emerging cause of community-acquired pneumonia (CAP).
- Key pathogens include Pseudomonas aeruginosa, Enterobacteriaceae, and Acinetobacter baumannii, with prevalence varying geographically.
- These infections are linked to increased disease severity and poorer patient outcomes.
Purpose of the Study:
- To review the epidemiology, risk factors, diagnostic approaches, and therapeutic strategies for gram-negative bacteria in CAP.
- To highlight the challenges posed by antibiotic resistance in treating these infections.
Main Methods:
- This narrative review synthesizes current literature on gram-negative CAP.
- Focuses on epidemiological data, clinical risk factors, diagnostic modalities, and treatment options.
Main Results:
- Gram-negative bacteria, particularly resistant strains, are significant contributors to CAP. Risk factor identification requires local validation due to heterogeneity in definitions.
- Molecular diagnostics offer promising avenues for rapid pathogen detection.
- Increasing antibiotic resistance complicates treatment choices.
Conclusions:
- Accurate identification of gram-negative pathogens in CAP is critical for patient management.
- Addressing antimicrobial resistance is essential for improving therapeutic efficacy.
- Further research and local validation of risk factors and diagnostic tools are needed.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Development of Antibiotic Resistance
01:31Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pneumonia II: Pathophysiology